Nurse Practitioner in East Winthrop, ME Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Ms. Ruth Elizabeth Cumler, PMHNP, APRN-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2402 Us Route 202, East Winthrop, ME 04343 Phone: 207-208-0925 Fax: 207-204-3264 |
News Archive
Penn researchers demonstrate new app to optimize acute stroke care
Stroke researchers from the Perelman School of Medicine at the University of Pennsylvania will unveil a map demonstrating geographic hotspots of increased stroke mortality across the United States, among a series of stroke studies being presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.
New saliva tests can enable early detection and diagnosis of COVID-19, head & neck cancer
Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.
Taxes, Medicare cuts and insurance provisions in reform bills spark worry
The Washington Post reports on seniors "remaining wary:" "Proposals to squeeze more than $500 billion out of the growth of Medicare over the next decade have fueled fears that his effort to expand coverage to millions of younger, uninsured Americans will damage elder care. … From the raw numbers, it appears seniors are the net losers under bills approved by three House committees last week.
German life sciences entrepreneurs granted option to develop Aeterna Zentaris' oral allogenic tumor vaccine technology
Aeterna Zentaris Inc. today announced that it has granted to German life sciences entrepreneurs with a proven track-record of funding the development and commercialization of biotechnology, an option to license the Company's live recombinant oral allogenic tumor vaccine technology, including AEZS-120, the most advanced product candidate for prostate cancer which is ready to enter a Phase 1 clinical trial.
Investment report on Sequenom from MicroStockProfit.com
MicroStockProfit.com announces an investment report featuring Sequenom Inc. The report includes financial, comparative and investment analysis, and industry information you need to know to make an educated investment decision.
› Verified 9 days ago